US scientists used low doses of the drug oxaliplatin to achieve almost complete remission in mice .
The problem is partly caused by immune system ‘B-cells’ that put a brake on the body’s defences in prostate and other cancers .
Each year in the UK 41,000 men are diagnosed with prostate cancer and 11,000 die from the disease .